The Recall Desk
ModerateFDA (Devices)·Z-1099-2021·Announced 2021-02-17

Cytocell Recalls Aquarius CRLF2 Distal Probe Due to Faint Signal Risk

Cytocell Ltd. is recalling 72 units of the Aquarius LPH 511-A CRLF2 Distal Probe Green because faint additional signals may cause normal samples to be misreported as abnormal.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source explicitly states there is a 'low risk' of misreporting and no injuries or illnesses are reported, fitting the criteria for a moderate severity precautionary recall.

Plain-English summary

Cytocell Ltd. is recalling 72 units of the Aquarius LPH 511-A CRLF2 Distal Probe Green, model no. LPH 511-A. The affected lots are 072240, 071390, and 072693. The product was distributed domestically to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington, as well as to Canada.

The recall is due to the potential for users to observe very faint additional locus-specific signals at 11q13. This issue creates a low risk that a normal sample may be incorrectly reported as not normal in a resulting laboratory developed test (LDT) that utilizes the probe.

Users of the affected probes should contact Cytocell Ltd. for further instructions on how to proceed with the recall.

The recalled product

Product
Aquarius LPH 511-A CRLF2 Distal Probe Green, model no. LPH 511-A The CRLF2 Distal probe, labelled in green, consists of two probes (71kb and 131kb) that are situated distal (telomeric) to the CRLF2 gene
Manufacturer
Cytocell Ltd.
Affected units
72

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lots 072240
  • 071390
  • and 072693

Distribution

Distributed in 7 states: